Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.

Roberts, Jillian; White, Bethany; Attalla, Dena; Ward, Stephen; Dunlop, Adrian J

Roberts, Jillian; White, Bethany; Attalla, Dena; Ward, Stephen; Dunlop, Adrian J.

Roberts J; Justice Health and Forensic Mental Health Network, Sydney, NSW, Australia.
White B; Sydney Local Health District, NSW, Australia.
Attalla D; Discipline of Addiction Medicine, Faculty of Medicine and Health, University of Sydney, NSW, Australia.
Ward S; Justice Health and Forensic Mental Health Network, Sydney, NSW, Australia.
Dunlop AJ; Justice Health and Forensic Mental Health Network, Sydney, NSW, Australia.

Addiction ; 116(2): 426-427, 2021 02.

Article in English | MEDLINE | ID: covidwho-1035485

Subject(s)

Buprenorphine/therapeutic use; COVID-19/prevention & control; Narcotic Antagonists/therapeutic use; Opiate Substitution Treatment/methods; Opioid-Related Disorders/drug therapy; Prisons; Humans; New South Wales; Pandemics; SARS-CoV-2

Keywords

Buprenorphine; CAM2038; COVID-19; depot; jail; long-acting; opioid dependence; opioid use disorder; prison; slow-release

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prisons / Buprenorphine / Opiate Substitution Treatment / COVID-19 / Narcotic Antagonists / Opioid-Related Disorders Limits: Humans Country/Region as subject: Oceania Language: English Journal: Addiction Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article Affiliation country: Add.15244

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google